Andrew Chen

Managing Director, EY-Parthenon, Ernst & Young (China) Advisory Limited

Andrew Chen is a managing director in the EY-Parthenon practice of Ernst & Young (China) Advisory Limited, heading the EY-Parthenon Shanghai office. Andrew focuses on business strategy, market and growth initiatives for the health care and consumer industries. He has more than a decade of experience as an entrepreneur, consultant and M&A vice president at a leading life science company in the US and China. Andrew is the advisor to a wide range of global and Chinese private equity and corporate players, covering inbound and outbound deal structuring advisory, globalization strategy, strategic due diligence and growth initiatives to fulfill the chief executive officer’s agenda. In his most recent role, Andrew was the provider and medtech leader at Boston Consulting Group’s Greater China office.

Andrew holds a BSE in Biomedical and Financial Engineering from the University of Michigan, Ann Arbor, and a GEMBA degree from CEIBS-IMD. He is also Lean Six Sigma Black Belt Certified.

Events Andrew Chen has attended as a speaker: